Viking Therapeutics

US · VKTX #2352 by market cap Listed 2015

28.54 +0.16 +0.56%

Live - 5344 symbols - heartbeat 335s ago · 2026-10-08 07:00

Pre-market 28.50 -0.14%

After-hours 28.62 +0.29%

Overnight 28.41 -0.46%

Market cap: 3.59B
P/E (TTM): -6.11
P/B: 8.78
EPS: -3.19
Div yield: 0.00%
52W pos: 16%

Reader sentiment Are you bullish or bearish on VKTX?

Anonymous reader poll. Unscientific, not investment advice.

About Viking Therapeutics

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Founded: 2012
CEO: Dr. Brian Lian, PhD
Employees: 53
Headquarters: San Diego, California, United States of America
Fiscal year end: 12-31
Website: vikingtherapeutics.com

Company profile

Exchange: US
Symbol: VKTX
Market-cap rank: #2352
Listing date: 2015-04-29
Market cap: 3.59B
Float cap: 3.50B
Shares out: 125.69M
Float shares: 122.77M

Sectors & themes

Biotechnology Weight Loss Drugs Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 07:00:13 · For reference only, not investment advice and not tailored to your situation.